Prof. Dr. Jonas Bergquist, University of Uppsala, Sweden, investigated antibodies against adrenergic receptors (a1, a2, b1, b2, b3) and acetylcholine muscarinergic receptors (M1-5) in two Swedish CFS/ME cohorts. For M3R-Ab and M4R-Ab a significant increase in antibody levels was found in CFS/ME patients compared to controls in both cohorts, for b1-adr-R-Ab and b2-adr-R-Ab only in one cohort.
2020 Brain Behaviour Immunity – Health – Uppsala – Bergquist CFS 1-s2.0-S2666354620300727-main